BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 25505035)

  • 1. Occipital nerve block for the short-term preventive treatment of migraine: A randomized, double-blinded, placebo-controlled study.
    Dilli E; Halker R; Vargas B; Hentz J; Radam T; Rogers R; Dodick D
    Cephalalgia; 2015 Oct; 35(11):959-68. PubMed ID: 25505035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term effects of greater occipital nerve blocks in chronic migraine: A double-blind, randomised, placebo-controlled clinical trial.
    Cuadrado ML; Aledo-Serrano Á; Navarro P; López-Ruiz P; Fernández-de-Las-Peñas C; González-Suárez I; Orviz A; Fernández-Pérez C
    Cephalalgia; 2017 Aug; 37(9):864-872. PubMed ID: 27296456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term efficacy of a double-blind, placebo-controlled, randomized study for repetitive sphenopalatine blockade with bupivacaine vs. saline with the Tx360 device for treatment of chronic migraine.
    Cady RK; Saper J; Dexter K; Cady RJ; Manley HR
    Headache; 2015 Apr; 55(4):529-42. PubMed ID: 25828648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of combination treatment of topiramate and greater occipital nerve block versus topiramate monotherapy for the preventive treatment of chronic migraine: A randomized controlled trial.
    Chowdhury D; Mundra A; Datta D; Duggal A; Krishnan A; Koul A
    Cephalalgia; 2022 Aug; 42(9):859-871. PubMed ID: 35259978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasound-guided greater occipital nerve block: an efficient technique in chronic refractory migraine without aura?
    Palamar D; Uluduz D; Saip S; Erden G; Unalan H; Akarirmak U
    Pain Physician; 2015; 18(2):153-62. PubMed ID: 25794201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Greater occipital nerve blockade for the preventive treatment of chronic migraine: A randomized double-blind placebo-controlled study.
    Chowdhury D; Tomar A; Deorari V; Duggal A; Krishnan A; Koul A
    Cephalalgia; 2023 Feb; 43(2):3331024221143541. PubMed ID: 36739512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Occipital Nerve Blocks for Acute Pain Relief of Migraines.
    Ebied AM; Nguyen DT; Dang T
    J Clin Pharmacol; 2020 Mar; 60(3):378-383. PubMed ID: 31595507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Greater occipital nerve block in chronic migraine.
    Saracco MG; Valfrè W; Cavallini M; Aguggia M
    Neurol Sci; 2010 Jun; 31 Suppl 1():S179-80. PubMed ID: 20464617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Greater occipital and supraorbital nerve blockade for the preventive treatment of migraine: a single-blind, randomized, placebo-controlled study.
    Özer D; Bölük C; Türk Börü Ü; Altun D; Taşdemir M; Köseoğlu Toksoy C
    Curr Med Res Opin; 2019 May; 35(5):909-915. PubMed ID: 30285507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Greater occipital nerve blockade for the treatment of chronic migraine: a randomized, multicenter, double-blind, and placebo-controlled study.
    Inan LE; Inan N; Karadaş Ö; Gül HL; Erdemoğlu AK; Türkel Y; Akyol A
    Acta Neurol Scand; 2015 Oct; 132(4):270-7. PubMed ID: 25765043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of galcanezumab in patients for whom previous migraine preventive medication from two to four categories had failed (CONQUER): a multicentre, randomised, double-blind, placebo-controlled, phase 3b trial.
    Mulleners WM; Kim BK; Láinez MJA; Lanteri-Minet M; Pozo-Rosich P; Wang S; Tockhorn-Heidenreich A; Aurora SK; Nichols RM; Yunes-Medina L; Detke HC
    Lancet Neurol; 2020 Oct; 19(10):814-825. PubMed ID: 32949542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Randomized, Sham-Controlled Trial of Bilateral Greater Occipital Nerve Blocks With Bupivacaine for Acute Migraine Patients Refractory to Standard Emergency Department Treatment With Metoclopramide.
    Friedman BW; Mohamed S; Robbins MS; Irizarry E; Tarsia V; Pearlman S; John Gallagher E
    Headache; 2018 Oct; 58(9):1427-1434. PubMed ID: 30144034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study.
    Bigal ME; Dodick DW; Rapoport AM; Silberstein SD; Ma Y; Yang R; Loupe PS; Burstein R; Newman LC; Lipton RB
    Lancet Neurol; 2015 Nov; 14(11):1081-90. PubMed ID: 26432182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine: A Randomized Clinical Trial.
    Dodick DW; Silberstein SD; Bigal ME; Yeung PP; Goadsby PJ; Blankenbiller T; Grozinski-Wolff M; Yang R; Ma Y; Aycardi E
    JAMA; 2018 May; 319(19):1999-2008. PubMed ID: 29800211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do bilateral and unilateral greater occipital nerve block effectiveness differ in chronic migraine patients?
    Ünal-Artık HA; İnan LE; Ataç-Uçar C; Yoldaş TK
    Neurol Sci; 2017 Jun; 38(6):949-954. PubMed ID: 28247118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventive effect of greater occipital nerve block on severity and frequency of migraine headache.
    Kashipazha D; Nakhostin-Mortazavi A; Mohammadianinejad SE; Bahadoram M; Zandifar S; Tarahomi S
    Glob J Health Sci; 2014 Jul; 6(6):209-13. PubMed ID: 25363127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
    Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
    Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of greater occipital nerve blockade in chronic migraine: A placebo-controlled study.
    Gul HL; Ozon AO; Karadas O; Koc G; Inan LE
    Acta Neurol Scand; 2017 Aug; 136(2):138-144. PubMed ID: 27910088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind, placebo-controlled study of repetitive transnasal sphenopalatine ganglion blockade with tx360(®) as acute treatment for chronic migraine.
    Cady R; Saper J; Dexter K; Manley HR
    Headache; 2015 Jan; 55(1):101-16. PubMed ID: 25338927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
    Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM;
    Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.